- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06888544
Effects of High-Intensity Interval Training on Bone Health in Hong Kong Older Women
Effects of High-Intensity Interval Training on Bone Health, Physical Fitness and Quality of Life in Elderly Women With Osteopenia: A Pilot Randomized Controlled Trial
Osteoporosis is an age-related disease, characterized by a decreased bone mass and an increased risk of fragility fractures. Osteoporosis leads to increasing mortality, disabilities, morbidity of chronic pain, and the cost of health and social care, as well as decreasing the quality of life from reduced independence and hindered physical, mental, and social well-being.
A recent review and meta-analysis, investigating the association between physical activity and osteoporosis prevention in elderly people, indicated that the traditional exercise interventions (i.e., resistance training) were undertaken for 60+ mins, 2-3 times/week for 7+ months. However, participation rates remain low in these exercise programs among older adults, in part due to a need for specialized equipment and correct techniques to prevent injury. In addition, low motivation and associated compliance with such conventional exercise is problematic among older adults.
Considering there is little evidence of HIIT benefits related to older women with osteopenia, the current study aims to evaluate the effectiveness of a 24-week HIIT intervention on bone mineral density, bone turnover markers and other health-related outcomes among Hong Kong Chinese older women.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yanping Duan
- Phone Number: 34115638
- Email: duanyp@hkbu.edu.hk
Study Locations
-
-
Hong Kong
-
China, Hong Kong, China, 999077
- Recruiting
- Bliss District Elderly Community Centre
-
Contact:
- Nathan
- Phone Number: 852+66879851
- Email: boplus@hkcs.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
• 60 to 74 years at the start date of the project
- diagnosed with osteopenia by DXA scan screening with a BMD at the femoral neck or total hip or lumbar spine between -1 and -2.5 SD T-score below the average values
- Passing the PAR-Q plus screening or with the physician's approval for readiness to participate in high-intensity exercise
- Above the average level of 2-mins stepping showing competent aerobic fitness
- No restriction on physical mobility
- No cognitive impairment, as determined by the Chinese version of the Mini-Mental Status Examination (i.e., score < 24)
- No previous substantial experiences in practicing HIIT. The written informed consent form will be collected from each participant
Exclusion Criteria:
• Severe chronic disease restricting high-intensity exercise
- Having cognition impairment regarded by specialists
- checked through medical records at HA Go app platform in the past 6 months, have concurrent medical conditions (e.g., thyrotoxicosis or hyperparathyroidism, Paget's disease, renal disease, diabetes, knee or hip osteoarthritis) and use medications (e.g., corticosteroids, estrogen, thyroxine, thiazide diuretics, or antiretroviral agents) known to affect bone metabolism during past 2 years
- any condition with osteoporosis, osteoporotic fractures
- current smoker
- alcohol 3 or more units per day.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High-intensity interval training (HIIT)
HIIT program for 24 weeks with a frequency of 2 times per week.
|
Participants will receive a 24-week HIIT program, with 2 sessions per week.
Each session will comprise three sections, including warm-up, main exercise and cool down.
The time will be between 37 to 40 minutes with progression of training.
Each HIIT section will include six high-impact weight-bearing exercise.
For Weeks 1-4, the HIIT section will include 12 intervals of 30 seconds HIIT workout at corresponding intensity, separated by 11 intervals of 60 seconds of active recovery.
To ensure the subjects' safety, a chair will be used for assistance during training in the first month.
Additionally, a 3 kg weight will be incorporated for the training in the final two months.
|
|
Placebo Comparator: Non-exercise control
Participants will not receive any exercise training but will attend 48 recreation workshops.
|
Workshop participants in the non-exercise control group will receive a series of workshops related to daily recreation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bone mineral density
Time Frame: Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
Bone mineral density at the non-dominant lumbar spine and femoral neck of hip will be measured by one registered technician using DXA (XR-46, Norland, Wisconsin, USA) at an assessment center in the Chinese University of Hong Kong.
|
Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
|
Bone turnover markers
Time Frame: Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
The two bone turnover markers, P1NP (ng/ml) and CTX (ng/L) will be used to assess the subjects' bone formation and bone resorption.
Participants must arrive at the elderly center between 08:30 and 09:30 a.m. after a 12-hour overnight fast and avoid intense physical activity the night before.
A qualified nurse will collect 5 mL of venous blood from the antecubital vein, which will coagulate at room temperature for 20-30 minutes before being transported to the lab within one hour.
The blood will then be centrifuged at 4 °C and 3000 rpm for 50 minutes, with the resulting sample stored at -80 °C for serum biochemical marker assays.
Serum P1NP and CTX levels will be measured using ELISA kits from Immunodiagnostic Systems Inc., and analysis will be conducted by the Hong Kong Polytechnic University test lab.
|
Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical fitness_Body mass index
Time Frame: Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
BMI (kg/m²) was calculated by dividing weight in kilograms by the square of height in meters.
Body weight was measured using a mobile scale that was accurate to 0.01 kg and calibrated before use.
Participants were instructed to remain still until the digital display stabilized, at which point their weights were recorded.
Height was measured using a mobile stadiometer accurate to 0.1 cm, and participants were asked to stand straight with their knees together during the measurement.
|
Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
|
Physical fitness_Lower limb muscle strength
Time Frame: Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
30-Second Chair Stand will used to assess lower limb muscle strength.
The required tools will include a straight-backed chair (43 cm seat height) and a timer.
Participants will sit in the middle of the chair with their feet shoulder-width apart, crossing their arms at the wrists close to their chest.
They will then stand fully and sit back down, counting this as one movement, which will be repeated for 30 seconds after the initial instruction.
|
Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
|
Physcal fitness_Upper limb muscle strength
Time Frame: Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test)
|
30-second Arm Curl will be used to evaluate upper limb muscle strength.
This test will measure upper body strength using a 5-pound dumbbell, a chair without armrests, and a timer.
Conducted on the stronger arm, participants will curl their arm through a full range of motion, turning the palm upward.
They will fully bend and straighten the arm at the elbow, repeating this as many times as possible within 30 seconds.
|
Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test)
|
|
Physical fitness_Aerobic endurance
Time Frame: Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
Aerobic endurance will be measured by a 2-Minute Step Test.
A timer will be used for this procedure.
Participants will stand straight next to a wall, where a mark will indicate the midpoint between the kneecap and hip bone.
They will step for two minutes, lifting their knees to the mark's height.
|
Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
|
Physical fitness_Lower body flexibility
Time Frame: Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
Lower body flexibility will be assessed by a Chair Sit-and-Reach Test.
The required tools will include a ruler and a straight-backed chair about 43 cm high.
Participants will sit on the edge of the chair, with one foot flat on the floor and the other leg extended forward, keeping the knee straight and the ankle at a 90° angle.
They will reach forward toward their toes with overlapping hands, maintaining a straight back and keeping their heads up.
The distance from their fingertips to their toes will be measured and held for a moment.
|
Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
|
Physical fitness_Upper body flexibility
Time Frame: Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
Upper body flexibility will be assessed by the Back Scratch Test.
The required tool will be a ruler.
Participants will place one hand behind their head and over their shoulder, reaching as far as possible with the palm against the body and fingers pointing down.
The other arm will be positioned behind the back, with the palm facing outward and fingers pointing up, reaching to overlap the fingertips of both hands.
The distance between the tips of the middle fingers will be measured.
|
Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
|
Physical fitness_Mobility and dynamic balance
Time Frame: Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
Mobility and dynamic balance will be measured by the 8-Foot Up-and-Go Test.
The required tools will include a timer, a straight-backed chair about 43 cm high, a cone marker, and a measuring tape.
The cone will be placed 2.4 m in front of the chair.
Participants will start by sitting with their hands on their knees and feet flat on the ground.
They will then stand up and walk quickly (without running) to round the cone and return to sit down.
The time taken from standing to sitting will be measured.
|
Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
|
Fear of falling
Time Frame: Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
Fear of falling (FOF) will be measured using the Chinese version of the Falls Efficacy Scale-International (FES-I).
This scale includes questions adapted from the original 16-item FES-I questionnaire to evaluate FOF during specific daily activities.
The total score of the questionnaire ranges from 16 to 64, and a higher score indicates that the individual perceives themselves as having a significant fear of falling, which can lead to reduced activity levels and an increased risk of social isolation.
The Chinese version of SFES-I demonstrated good internal consistency and reliability, with a Cronbach's α of 0.88.
|
Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
|
Perceived quality of life
Time Frame: Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
The quality of life will be assessed using the brief version of the Hong Kong Chinese WHO Quality of Life Scale (WHOQOL-BREF) (Cronbach's α = .73
- .84).
The scale includes 28 items, covering four dimensions of how older adults perceive their quality of life.
The total score of the questionnaire ranges from 28 to 140, and a higher score indicates that the individual feels they have a high quality of life.
|
Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart rate
Time Frame: Heart rate will be monitored from the start of warm-up to the end of cool-down at each exercise session during the 24-weeks exercise intervention.
|
Participants will be monitored by Polar verity sensor during exercise and their heart rate will be monitored to ensure their safety and intensity adherence of exercise protocol.
|
Heart rate will be monitored from the start of warm-up to the end of cool-down at each exercise session during the 24-weeks exercise intervention.
|
|
Self-reported Rate of Perceived Exertion (RPE)
Time Frame: RPE will be asked at the end of main exercise at each exercise session during the 24-weeks intervention
|
Older women will be asked about the self-reported Rate of Perceived Exertion (RPE Borg CR-10 category scale) after they complete the main exercise training in each session.
A higher score (closer to 10) means the individual feels they are working much harder, while a lower score (closer to 0) suggests a much easier level of activity.
|
RPE will be asked at the end of main exercise at each exercise session during the 24-weeks intervention
|
|
Safety: adverse events
Time Frame: Adverse events will be asked at the end of each exercise session during the 24-weeks intervention program
|
All adverse events will be recorded as safety endpoints.
|
Adverse events will be asked at the end of each exercise session during the 24-weeks intervention program
|
|
Exercise acceptability
Time Frame: The exercise acceptability will be evaluated after 24 weeks of intervention.
|
Exercise acceptability will be assessed post-intervention using ten questionnaire items responding to a 5-point Likert scale (strongly disagree, disagree, neither agree nor disagree, agree, and strongly agree).
The score on this scale ranges from 9 to 40, the higher score shows better acceptability to the exercise intervention.
|
The exercise acceptability will be evaluated after 24 weeks of intervention.
|
|
Process evaluation of intervention program
Time Frame: Outcome evaluations will be conducted at the completion of 24-weeks intervention
|
A process evaluation scale of the intervention process will be developed for this study based on the previous framework of process evaluation for the intervention study.
This scale with 10 items using a 5-point (strongly unsatisfied, unsatisfied, neutral, satisfied, and strongly satisfied).
The score on this scale ranges from 10 to 50, a higher score shows higher satisfaction with the intervention program.
|
Outcome evaluations will be conducted at the completion of 24-weeks intervention
|
|
Retention rate
Time Frame: Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
Percentage of participants completing assessments at the pre-intervention test, post-intervention test and follow up test
|
Outcome evaluations will be performed three times at pre-intervention (T1 baseline), after 24-weeks intervention (T2 post-test), and 6 months after intervention completion (T3 follow-up test).
|
|
Session attendance rate
Time Frame: Session attendance will be recorded during the 24-week intervention
|
Percentage of participants completed at least 75% of intervention sessions (36/48 sessions).
|
Session attendance will be recorded during the 24-week intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yanping Duan, Hong Kong Baptist University; Department of Sport, Physical Education and Health
Publications and helpful links
General Publications
- Grant A, Treweek S, Dreischulte T, Foy R, Guthrie B. Process evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting. Trials. 2013 Jan 12;14:15. doi: 10.1186/1745-6215-14-15.
- Carlson SA, Fulton JE, Schoenborn CA, Loustalot F. Trend and prevalence estimates based on the 2008 Physical Activity Guidelines for Americans. Am J Prev Med. 2010 Oct;39(4):305-13. doi: 10.1016/j.amepre.2010.06.006.
- Chapman, J. J., Coombes, J. S., Brown, W. J., Khan, A., Chamoli, S., Pachana, N. A., & Burton, N. W. (2017). The feasibility and acceptability of high-intensity interval training for adults with mental illness: A pilot study. Mental Health and Physical Activity, 13, 40-48
- Kwan MM, Tsang WW, Close JC, Lord SR. Development and validation of a Chinese version of the Falls Efficacy Scale International. Arch Gerontol Geriatr. 2013 Jan-Feb;56(1):169-74. doi: 10.1016/j.archger.2012.10.007. Epub 2012 Oct 30.
- Marriott CFS, Petrella AFM, Marriott ECS, Boa Sorte Silva NC, Petrella RJ. High-Intensity Interval Training in Older Adults: a Scoping Review. Sports Med Open. 2021 Jul 19;7(1):49. doi: 10.1186/s40798-021-00344-4.
- Zitzmann AL, Shojaa M, Kast S, Kohl M, von Stengel S, Borucki D, Gosch M, Jakob F, Kerschan-Schindl K, Kladny B, Lange U, Middeldorf S, Peters S, Schoene D, Sieber C, Thomasius F, Uder M, Kemmler W. The effect of different training frequency on bone mineral density in older adults. A comparative systematic review and meta-analysis. Bone. 2022 Jan;154:116230. doi: 10.1016/j.bone.2021.116230. Epub 2021 Oct 5.
- Lin CY, Park JH, Hsueh MC, Sun WJ, Liao Y. Prevalence of Total Physical Activity, Muscle-Strengthening Activities, and Excessive TV Viewing among Older Adults; and Their Association with Sociodemographic Factors. Int J Environ Res Public Health. 2018 Nov 8;15(11):2499. doi: 10.3390/ijerph15112499.
- Pinheiro MB, Oliveira J, Bauman A, Fairhall N, Kwok W, Sherrington C. Evidence on physical activity and osteoporosis prevention for people aged 65+ years: a systematic review to inform the WHO guidelines on physical activity and sedentary behaviour. Int J Behav Nutr Phys Act. 2020 Nov 26;17(1):150. doi: 10.1186/s12966-020-01040-4.
- Nguyen VH. Osteoporosis prevention and osteoporosis exercise in community-based public health programs. Osteoporos Sarcopenia. 2017 Mar;3(1):18-31. doi: 10.1016/j.afos.2016.11.004. Epub 2016 Dec 24.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HMRF07220048
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteopenia
-
Instituto de Investigación Hospital Universitario...Completed
-
Naturex SAAtlantia Food Clinical TrialsCompletedOsteopenia, GeneralizedIreland
-
Ioannis K. Triantafyllopoulos, MD,MSci,PhDCompletedOsteopenia | Postmenopausal Osteopenia
-
National and Kapodistrian University of AthensNational Hellenic Research FoundationCompletedOsteopenia | Postmenopausal OsteopeniaGreece
-
Chinese PLA General HospitalBeijing Jishuitan Hospital; Beijing Aerospace General HospitalUnknownOsteoporosis | Osteopenia, OsteoporosisChina
-
NestléInstitut National de la Recherche Agronomique; Centre de Recherche en Nutrition...CompletedOsteoporosis, OsteopeniaFrance
-
Second Xiangya Hospital of Central South UniversityCompletedOsteoporosis, OsteopeniaChina
-
California State University, San MarcosCompletedOsteoporosis, Osteopenia
-
Universidade Federal de PernambucoFundação de Amparo à Ciência e Tecnologia do Estado de PernambucoCompletedOsteoporosis | Senile OsteopeniaBrazil
-
MeddocThe Research Council of Norway; TineRecruitingOsteopenia or OsteoporosisNorway
Clinical Trials on HIIT program for 24 weeks with a frequency of 2 times per week.
-
Eunice Kennedy Shriver National Institute of Child...National Institute on Aging (NIA)Completed
-
Grifols Therapeutics LLCWithdrawnPrimary ImmunodeficiencyUnited States
-
University Hospital, RouenRecruiting
-
Cairo UniversityRecruitingAdhesive Capsulitis of ShoulderEgypt
-
Universidade Federal do Rio de JaneiroCompletedAssessment of Muscle Architecture and Tendon After Chronic Stretching ProgramBrazil
-
University of VigoUnknownQuality of Life | Healthy | Physical Activity | AgingSpain
-
Escola Superior de Tecnologia da Saúde do PortoCompleted
-
National Taipei University of Nursing and Health...Recruiting
-
Nationwide Children's HospitalNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedDuchenne Muscular DystrophyUnited States
-
Huashan HospitalEnrolling by invitationAntifungal Agents | Cryptococcal MeningitisChina